Biological markers and colorectal cancer

JK Practitioner

Volumn 9, Issue 4, 2002, Pages 215-218

  Sheikh, Rafiq A ^a   Yasmeen, Shagufta ^b   Prindiville, Thomas ^c   Ruebner, B H ^c  

^a SAN JOAQUIN GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BIOLOGICAL MARKER; BROXURIDINE; CYCLINE; DNA; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ADNAB 9; PROTEIN P53; THYMIDINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADENOMA; ANEUPLOIDY; APOPTOSIS; BENIGN TUMOR; CANCER INHIBITION; CANCER INVASION; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CARCINOMA IN SITU; CAUSE OF DEATH; CELL CYCLE; CELL DEATH; CELL MATURATION; CELL PROLIFERATION; CHROMOSOME 17; CHROMOSOME ARM; CLINICAL FEATURE; COLON CANCER; COLORECTAL CANCER; DISEASE SEVERITY; DNA REPAIR; DYSPLASIA; EDITORIAL; ENDOSCOPIC POLYPECTOMY; ENDOSCOPIC SURGERY; EVIDENCE BASED MEDICINE; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; HEREDITY; HUMAN; IMMUNOCYTOCHEMISTRY; INTESTINE TUMOR; MALIGNANT TRANSFORMATION; MITOSIS; ONCOGENE; ONCOGENE K RAS; PLOIDY; POLYP; PREVALENCE; PROGNOSIS; TUMOR SUPPRESSOR GENE; UNITED STATES; WILD TYPE;

EID: 0036812634     PISSN: 09718834     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (58)

1. Wingo PA, Tong T, Bolden S. Cancer statistics 1995. CA Cancer J Clin 1995; 45: 8-30.
2. Tomlinson I, Ilyas M, Novelli M. Molecular genetics of colon cancer. Cancer and Metastasis Reviews 1997; 16: 67-79.
3. Itzkowitz SH. The adenomatous polyp. Semin Gastrointest Dis 1992; 3: 3-12.
4. Correa P, Strong JP, Reif A, et al. The epidemiology of colorectal polyps: prevalence in New Orleans and international comparisons. Cancer 1977; 39: 2258-64.
5. Jackman RJ, Mayo CW. The adenoma-carcinoma sequence in cancer of the colon. Surg Gynecol Obstet 1951; 93: 327-30.
6. Morson BC. The polyp-cancer sequence in the large bowel. Proc R Soc Med 1974; 67: 451-57.
7. Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 225-70.
8. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colo-rectal tumor development. N Eng J Med 1988; 319: 525-32.
9. Atkins WS, Morson BC, Cuzick J. Long term risk of colorectal cancer after excision of rectosigmoid adenomas. N Eng J Med 1992; 326: 658-62.
10. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1900; 61: 769-67.
11. Bond JH. Polyp guidelines: diagnosis, treatment and surveillance for patients with nonfamilial colorectal polyps. Ann Int Med 1993; 119: 836-43.
12. Winawer SJ, Zauber AG, Nah HOMS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Eng J Med 1993; 329: 1977-81.
13. Hackelsberger A, Fruhmorgen P, Weiler H, et al. Endoscopic polypectomy and management of colorectal adenomas with invasive carcinoma. Endoscopy 1995; 27: 153-8.
14. Volk EE, Goldblum JR, Petras RE, et al. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology 1995; 109: 1801-7.
15. Cooper HS, Deppisch LM, Gourley WK, et al. Endoscopically removed malignant colorectal polyps: clinicopathological correlations. Gastroenterology 1995; 108: 1657-65.
16. Ronucci L, Stamp D, Medline A, et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Human Pathol 1991; 22: 287-94.
17. Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplastic foci in colonic mucosa. Cancer Res 1991; 51: 1564-7.
18. Jen J, Powel SM, Papadopoulos N, et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994; 54: 5523-6.
19. Watne AL. Colon polyps. Jr Surg Oncol 1997; 66: 207-14.
20. Goodlad RA, Wright NA. Growth factors in the gastrointestinal tract. Bailliere's Clin Gastroenterol 1990; 4; 97: 118.
21. Baldwin GS, Whitehead RH. Gut harmones, growth and malignancy. Bailliere's Clin Endocrinol Metab 1994; 8: 185-214.
22. Gerdes J, Lemke H, Baisk H, et al. Cell cycle analysis of the cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-5.
23. Kyzer S, Gordon PH. Determination of proliferative activity in colorectal carcinoma using monoclonal antibody Ki-67. Dis Colon Rectum 1997; 40: 322-5.
24. Carr NJ, Monihan JM, Nzeako UC, et al. Expression of proliferating cell nuclear antigen in hyperplastic polyps, adenomas and inflammatory cloacogenic polyps of the large bowel. J Clin Pathol 1995; 48: 46-52.
25. Al-Sheneber IF, Shibata HR, Sampalis J, et al. Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 1993; 71: 1954-9.
26. Vogelstein B, Kinzler KW. P53 function and dysfunction. Cell 1992; 70: 523-26.
27. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the P53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.
28. Rodrigues NR, Rowan A, Smith MEF, et al. P53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990; 87: 7555-59.
29. Fearson ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987; 238: 193-7.
30. Wolly RC, Schreiber K, Koss LG, et al. DNA distribution in human colon carcinomas and its relationship to clinical behaviour. J Natl Cancer Inst 1982; 69: 15-22.
31. Kokal W, Sheibani K, Terz J, et al. Tumor DNA content in the prognosis of colorectal carcinoma. JAMA 1986; 255: 3123-27.
32. Armitage NC, Robins RA, Evans DF, et al. The influence of tumor cell DNA abnormalities on survival in colorectal cancer. Br J Surg 1985; 72: 828-30.
33. Rognum TO, Thorud E, Elgjo K, et al. Large bowel carcinomas with different ploidy, related to secretory component IgA and CEA in epithelium and plasma. Br J Cancer 1982; 45: 921-34.
34. Freed DLJ, Taylor G. Carcinoembryonic antigen in feces. Br Med J 1972; 1: 85-7.
35. Elias EG, Holyoke ED, Chu TM. Carcinoembryonic antigen in feces and plasma of normal subjects and patients with colorectal carcinoma. Dis Col Rect 1974; 17: 138-41.
36. Winawer SJ, Groom G, Green S, et al. Carcinoembryonic antigen in colonic lavage. Gastroenterology 1977; 73: 719-22.
37. Stubbs RS, Nadkami DM, Monsey HA. Fecal carcinoembryonic antigen in colorectal cancer patients. Gut 1986; 27: 901-5.
38. Tobi M, Darmaon E, Phillips T, et al. Increased expression of a putative adenoma associated antigen in precolonoscopic effluent of patients with colorectal cancer. Cancer Lett 1990; 50: 21-5.
39. Tobi M, O'Kieffe D, Trujillo N, et al. Detection of carcinoembryonic antigen in colonic effluent by specific anti-CEA antibodies. Cancer Lett 1992; 67: 737-42.
40. Tobi M, Kaila V, Goo R, et al. An adenoma associated antigen as a preneoplastic marker in familial polyposis coli versus sporadic colonic neoplasia. Gastroenterology 1992; 102: A 403.
41. Tobi M, Maliakkal BJ, Zitron I, et al. Colonic effluent adenoma associated antigen correlated with colorectal cancer in a membrane bound glycoprotein. Cancer Lett 1992; 67: 61-9.
42. Eckardt VF, Fuchs M, Kanzler G, et al. Follow up of patients with colonic polyps containing severe atypia and invasive carcinoma: Compliance, recurrence and survival. Cancer 1988; 61: 2552-57.
43. Rossini FP, Ferrari A, Spandre M, et al. Colonoscopic polypectomy in the diagnosis and management of cancerous adenomas: An individual and multicenteric experience. Endoscopy 1982; 14: 124-27.
44. Silverberg SG. Focally malignant adenomatous polyps of the colon and rectum. Surg Gynecol Obstet 1970; 131: 103-14.
45. Bond JH. Update on the detection, management and follow-up of colorectal polyps. Practical Gastroenterol 1997; 21 (4): 15-29.
46. Zarchty TM, Ershoff D. Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy? Gastroenterology 1994; 106: 1501-4.
47. Grossman S, Milos MI, Tekawa IS, et al. Colonoscopic screening of persons with suspected risk factors for colon cancer, II: Past history of colorectal neoplasms. Gastroenterology 1989; 96: 299-306.
48. Lofti AM, Spencer RJ, Illstrup DM, et al. Colorectal polyps and the risk of subsequent carcinoma. Mayo Clin Proc 1986; 61: 337-43.
49. O'Brien MJ, Winawer SJ, Zauber AG, et al. National polyp study: Patient and polyp characteristics associated with high grade dysplasia in colorectal adenomas. Gastroenterology 1990; 98: 371-79.
50. Morson BC, Bussey HJR. Magnitude of risk for cancer in patients with colorectal adenomas. Br J Surg 1985; 72: S 23-28.
51. Wilcox GM, Beck JR. Early invasive cancer in adenomatous colonic polyps: Evaluation of the therapeutic options by decision analysis. Gastroenterology 1987; 92 (I): 1159-68.
52. Coverlizza S, Risio M, Ferrari A, et al. Colorectal adenomas containing invasive carcinoma: Pathological assessment of lymph node metastatic potential. Cancer 1989; 64: 1937-47.
53. Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer: Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985; 28: 383-8.
54. Itzkowitz SH, Kim YS. Colonic polyps and polyposis syndromes. In, Sleisenger and Fordtran's Gastrointestinal and Liver Disease; Philadelphia, WB Saunders and Company, ed 6th, p1865-1905.
55. Cooper HS. Surgical pathology of endoscopically removed malignant polyps of the colon and rectum. Am J Surg Pathol 1983; 7: 613-23.
56. Wilcox GM, Anderson PB, Colacchio TA. Early invasive carcinoma in colonic polyps: A review of the literature with emphasis on the assessment of the risk of metastasis. Cancer 1986; 57: 160.
57. Hofstad B, Vatn M, Larsen S, et al. In situ measurement of colorectal polyps to compare video and fiberoptic endoscopes. Endoscopy 1994; 26: 461.
58. Margulies C, Schoen RE, Gerber LD, et al. Inaccurate polyp size estimation can affect patient management: Endoscopic estimates should be abandoned in favor of the pathologist's measurement. Gastrointestin Endosc 1996; 43: 368.